65,437 trials
Opiate Dependence · Substance-related Disorders · Opioid-related Disorders
Primary: The Number of Participants Attaining Successful Opioid Use Outcome by Counseling Condition at End of Phase 1 — 19; 24 participants
Chronic Obstructive Pulmonary Disease
Primary: Trough Forced Expiratory Volume in 1 Second (FEV1) at Week 12 — 1.469; 1.372; 1.455 Liters
Anemia
Primary: Mean Change in Hemoglobin Between Baseline and the Evaluation Period — 11.22; 11.11; 10.78; 11.64 g/dL
Alzheimer's Disease
Primary: CERAD-K (the Korean Version of the Consortium to Establish a Registry for Alzheimer's Disease) — 8.28; 7.31; 17.86; 10.62 Units on Scale
Chronic Hepatitis C
Primary: Patients With Either Undetectable Serum HCV RNA (<100 Copies/ml) or at Least a 2-log Decrease From Baseline in Serum Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) at…
Schizophrenia
Primary: Mean Change in Negative Scale Scores From the Positive and Negative Syndrome Scale (PANSS) From Baseline to Endpoint — -2.0; -2.3; -2.1; -2.1 Units on a scale — p=0.8514
Acne Vulgaris
Primary: Percentage of Participants With at Least a One Point Decrease in the Global Acne Assessment Score (GAAS) at Week 12 — 69.7; 81.4 Percentage of participants
Influenza
Primary: Number of Subjects Reporting Any and Grade 3 Solicited Local Symptoms — 0; 1; 0; 0 Subjects
Crohn's Disease
Primary: Number of Participants With Clinical Response at Week 6 — 31; 48; 45; 52 Participants — p=0.005
Dyspepsia · Emergency · Pain
Primary: Pain Scores on the 100-millimeter Visual Analog Scale (VAS) at 1 Hour After Treatment — 17; 19 millimeter — p=0.6
Cardiovascular Diseases · Kidney Failure, Chronic
Primary: Dialysis Clearance of Dabigatran — 161; 241; 120; 183 mL/min
Schizophrenia
Primary: Mean for Attentional Standardised Composite Score Based on Performance Scores From the CogState Test Battery Domains Detection (Speed of Processing)and Identification…
Myelodysplastic Syndrome · Leukemia
Primary: Number of Participants With Response for Two Dose Schedules of Clofarabine — 10; 5; 5; 1 Participants
Alzheimer's Disease
Primary: Differences in Standard Uptake Value Ratio (SUVR) for Frontal Cortex/Cerebellum and Whole Brain/Cerebellum of the Positron Emission Tomography (PET) Scan With…
Epilepsy
Primary: The Percentage of Participants With Seizure Free Rate — 73.7; 83.1 percentage of participants